• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Epicore & Denka Partner to Tackle Dehydration Crisis in Asia via Sweat-Sensing Wearable

by Syed Hamza Sohail 08/30/2022 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know:

– Epicore Biosystems today announced a partnership with Denka Corporation, a Japan-based multinational technology and materials company.

– Under the agreement, Epicore Biosystems and Denka will collaborate on strategic initiatives to pilot and distribute Epicore’s portfolio of advanced wearable hydration solutions in Japan and expand into Asia markets. 

Tackling Asia’s Dehydration Crisis Through Sweat-Sensing Wearable Technology

Founded in 2017, Epicore Biosystems is a digital health company developing advanced sweat-sensing wearables that provide real-time personalized health insights for hydration, stress and wellness. Their clinically validated products are deployed globally and licensed by leading Fortune 500 companies, the Department of Defense and the National Institute of Health in the sports and fitness, occupational safety and clinical trials industries.

The partnership comes at a critical time as rising heatwaves continue to spread across Asia with no signs of slowing down as experts warn the world could hit a climate high by 2024. As a result, many Asia residents are experiencing excessive heat exposure and dehydration, which can have harmful effects on cognitive and physical performance, as well as physiological function. In June 2022 alone, more than 15,000 people needed hospital care across Japan. These issues are more notably visible among individuals in sports, industrial work, and military training, among others. 

Epicore Biosystems develops advanced wearable solutions that measure sweat biometrics and provide customized recovery insights about hydration, including sweat rate, total sweat loss, sodium chloride concentration and total sodium chloride loss — all captured with an unobtrusive wearable sweat sensor, analyzed through a proprietary cloud engine, and delivered directly to the wearer through a smartphone application and cloud portal. Denka and Epicore Biosystems will first survey the needs of those within the sports and wellness industries in Asia, with plans to expand into industrial and medical applications, such as identifying dehydration and fatigue in elderly patients, soon after.


“As temperatures continue to rise in countries around the globe, dehydration has become a leading cause of concern,” said Roozbeh Ghaffari, CEO and co-founder of Epicore Biosystems. “There is now an enormous demand to address these challenges and identify personalized solutions for tackling hydration problems before they impact long-term health. Our collaboration with Denka enables us to unlock new opportunities and address hydration challenges head-on within the Asia market.”

Sweat-Sensing Wearable Technology

Epicore Biosystems’ suite of sweat-sensing wearables includes the Gx Sweat Patch created in partnership with PepsiCo and Gatorade, the Discovery Patch® Sweat Collection System, and the Connected Hydration wearable hydration sensor and mobile application tailored for industrial athletes and sports. 

The technology has been developed and tested with leading sports physiology labs and research hospitals, including the Northwestern University Feinberg School of Medicine, University of Connecticut Korey Stringer Institute, University of Massachusetts Amherst Center for Human Health and Performance, and the Gatorade Sports Science Institute. 

Denka and Epicore Biosystems’ partnership officially went into effect this month with the goal to bring personalized hydration products to the Asia markets in the next 18 months.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Clinical Trials, cloud, department of defense, digital health, HIT, Portal, Wearables

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Virta Health CEO: GLP-1s Didn’t Kill Weight Watchers, Its Broken Model Did

Most-Read

Moving Beyond EHRs: What Lies Ahead for Healthcare Digitization?

AI Agents vs. Chatbots: Understanding Agentic AI’s Role in Healthcare

AI Breakthrough Reveals 2025 AI Breakthrough Award Winners

AI Breakthrough Reveals 2025 AI Breakthrough Award Winners

Healthcare's Big Blind Spot: The Measurement Crisis in Inpatient Psychiatry

Healthcare’s Big Blind Spot: The Measurement Crisis in Inpatient Psychiatry

Lessons Learned from The Change Healthcare Cyberattack, One Year Later

Lessons Learned from The Change Healthcare Cyberattack, One Year Later

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Omada Health Launches "Nutritional Intelligence" with AI Agent OmadaSpark

Omada Health Soars in NASDAQ Debut, Signaling Digital Health IPO Rebound

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |